Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress

Free Radical Biology and Medicine

Volumn 45, Issue 6, 2008, Pages 743-748

  Liu, Yifen ^a   Mackness, Bharti ^a   Mackness, Mike ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Atherosclerosis; Macrophages; Oxidised LDL; Paraoxonase 1; Paraoxonase 3

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PARAOXONASE 3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ARYLDIALKYLPHOSPHATASE; CELL LINE, TUMOR; CHOLESTEROL; ESTERASES; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION; OXIDATIVE STRESS; RECOMBINANT PROTEINS;

EID: 54949132152     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.05.024     Document Type: Article

References (23)

1. Steinberg D., and Witztum J.L. Is the oxidative modifications hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date reflect the hypothesis?. Circulation 105 (2002) 2107-2211
2. Mackness M.I., Durrington P.N., and Mackness B. How HDL protects against the effects of lipid peroxidation. Curr. Opin. Lipidol. 11 (2000) 383-388
3. Mackness M.I., Arrol S., Abbott C.A., and Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104 (1993) 129-135
4. Reddy S.T., Wadleigh D.J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D.M., Lusis A.J., Navab M., and Fogelman A.M. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidised lipids. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 542-545
5. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Fault K.F., Fogelman A.M., and Navab M. Protective effect of high density lipoprotein associated paraoxonase-inhibition of the biological activity of minimally oxidised low-density lipoprotein. J. Clin. Invest. 96 (2001) 2882-2891
6. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein and preserves its functions. J. Clin. Invest. 101 (1998) 1581-1590
7. Shih D.M., Gu L., Xia Y.-R., Navab M., Li W.-F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., and Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (1998) 284-287
8. Tward A., Xia Y.R., Wang X.P., Shi Y.S., Park C., Castellani L.W., Lusis A., and Shih D.H. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106 (2002) 484-490
9. Mackness B., Quarck R., Verreth W., Mackness M., and Holvoet P. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1545-1550
10. Brushia R.J., Forte T.M., Oda M.N., La Du B.N., and Bielicki J.K. Baculovirus-mediated expression and purification of human serum paraoxonase 1A. J. Lipid Res. 42 (2001) 951-958
11. Mackness B., Hine D., Liu Y., Mastorikou M., and Mackness M. Paraoxonase 1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem. Biophys. Res. Commun. 318 (2004) 680-683
12. Teiber J.F., Draganov D.I., and La Du B.N. Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH. J. Lipid Res. 45 (2004) 2260-2268
13. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., and La Du B.N. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 46 (2005) 1239-1247
14. Aviram M., and Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37 (2004) 1304-1316
15. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., and La Du B.N. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 275 (2000) 33435-33442
16. Shih D.M., Xia Y.R., Wang X.P., Wang S.S., Bourquard N., Fogelman A.M., Lusis A.J., and Reddy S.T. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ. Res. 100 (2007) 1200-1207
17. EL-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A.Y., and Jurgens G.A. Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30 (1989) 627-630
18. Jonas A., von Eckardstein A., Kézdy K.E., Steinmetz A., and Assmann G. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J. Lipid Res. 32 (1991) 97-106
19. Rochu D., Chabrière E., Renault F., Elias M., Cléry-Barraud C., and Masson P. Stabilization of the active form(s) of human paraoxonase by human phosphate-binding protein. Biochem. Soc. Trans. 35 (2007) 1616-1620
20. Josse D., Ebel C., Stroebel D., Fontaine A., Borges F., Echalier A., Baud D., Renault F., Le Maire M., Chabrieres E., and Masson P. Oligomeric states of the detergent solubilised human serum paraoxonase (PON1). J. Biol. Chem 277 (2002) 33386-33397
21. Deakin S., Leviev I., Gomaraschi M., Calabresi L., Franceschini G., and James R.W. Enzymatically active paraoxonase 1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem. 277 (2002) 4301-4308
22. Mackness M.I., Mackness B., Arrol S., Wood G., Bhatnager D., and Durrington P.N. Presence of paraoxonase in human interstitial fluid. FEBS Lett. 416 (1997) 377-380
23. Rozenberg O., Shih D.M., and Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 461-467